Gordana Babic Atallah

Gordana Babic Atallah

AbbVie Inc - Chicago / United States
Medical and Health Sciences / Pharmacy & Pharmaceutical Sciences
AD Scientific Index ID: 4402152
-
person_outline Gordana Babic Atallah's MOST POPULAR ARTICLES
1-) Identification of NVP-BKM120 as a potent, selective, orally bioavailable class I PI3 kinase inhibitor for treating cancerMT Burger, S Pecchi, A Wagman, ZJ Ni, M Knapp, T Hendrickson, ...ACS medicinal chemistry letters 2 (10), 774-779, 20112582011
2-) Development of novel antioxidants: design, synthesis, and reactivityHH Hussain, G Babic, T Durst, JS Wright, M Flueraru, A Chichirau, ...The Journal of organic chemistry 68 (18), 7023-7032, 20032612003
3-) Identification of N-(4-((1R,3S,5S)-3-Amino-5-methylcyclohexyl)pyridin-3-yl)-6-(2,6-difluorophenyl)-5-fluoropicolinamide (PIM447), a Potent and Selective Proviral …MT Burger, G Nishiguchi, W Han, J Lan, R Simmons, G Atallah, Y Ding, ...Journal of medicinal chemistry 58 (21), 8373-8386, 2015872015
4-) Discovery of novel 3, 5-disubstituted indole derivatives as potent inhibitors of Pim-1, Pim-2, and Pim-3 protein kinasesGA Nishiguchi, G Atallah, C Bellamacina, MT Burger, Y Ding, PH Feucht, ...Bioorganic & medicinal chemistry letters 21 (21), 6366-6369, 2011732011
5-) Discovery of potent and selective RSK inhibitors as biological probesR Jain, M Mathur, J Lan, A Costales, G Atallah, S Ramurthy, ...Journal of medicinal chemistry 58 (17), 6766-6783, 2015622015